PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT study

The traditional double blind RCT is the ‘gold standard’ trial design. For a variety of reasons, these designs often fail to accrue enough participants to conclude. This is particularly challenging in localized prostate cancer. The cohort multiple randomised controlled trial (cmRCT) trial design may...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Contemporary clinical trials 2021-08, Vol.107, p.106485-106485, Article 106485
Hauptverfasser:	Bass, E.J., Klimowska-Nassar, N., Sasikaran, T., Day, E., Fiorentino, F., Sydes, M.R., Winkler, M., Arumainayagam, N., Khoubehi, B., Pope, A., Sokhi, H., Dudderidge, T., Ahmed, H.U.
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical trials cmRCT Cohort multiple randomised controlled trial Double-Blind Method Feasibility Studies Health Personnel Humans Male Prospective Studies Prostate Prostate cancer Surveys and Questionnaires
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!